Men B dosing recommendations have changed

ACIP recommends TRUMENBA in a 2-dose schedule for healthy adolescents

The Advisory Committee on Immunization Practices (ACIP) now recommends a 2-dose schedule of TRUMENBA for healthy adolescents and young adults.

Previously, the ACIP recommended a 3-dose schedule. The 3-dose schedule is now only recommended for people at an increased risk for meningococcal disease or in an outbreak situation.

Dosing information

2-dose schedule, for healthy people aged 16 to 23 years who are not at increased risk for meningococcal disease:

  • Dose 1: administer at month 0
  • Dose 2: administer no sooner than 6 months after Dose 1

3-dose schedule, for people who are age 10 or over, and in an outbreak situation or at increased risk for meningococcal disease:

  • Dose 1: administer at month 0
  • Dose 2: administer 1-2 months after Dose 1
  • Dose 3: administer no sooner than 6 months after Dose 1

Further Information

For more information, see:

Note: Bexsero may still  be used for any adolescent as a 2-dose series at 0 months and under 1 month. See full prescribing information from GSK.